Correction and use of biomedical literature affected by scientific misconduct

Abstract

The purpose of this study was to identify and describe published research articles that were named in official findings of scientific misconduct and to investigate compliance with the administrative actions contained in these reports for corrections and retractions, as represented in PubMed. Between 1993 and 2001, 102 articles were named in either the NIH Guide for Grants and Contracts (“Findings of Scientific Misconduct”) or the U.S. Office of Research Integrity annual reports as needing retraction or correction. In 2002, 98 of the 102 articles were indexed in PubMed. Eighty-five of these 98 articles had indexed corrections: 47 were retracted; 26 had an erratum; 12 had a correction described in the “comment” field. Thirteen had no correction, but 10 were linked to the NIH Guide “Findings of Scientific Misconduct”, leaving only 3 articles with no indication of any sort of problem. As of May 2005, there were 5,393 citations to the 102 articles, with a median of 26 citations per article (range 0–592). Researchers should be alert to “Comments” linked to the NIH Guide as these are open access, and the “Findings of Scientific Misconduct’ reports are often more informative than the statements about the retraction or correction found in the journals.

Appendix

Bibliography of 102 articles identified in final reports of “Findings of Scientific Misconduct” (from either the NIH Guide for Grants and Contracts or the Office of Research Integrity Annual Reports 1993–2001). Respondents named in these findings of scientific misconduct are in bold

A1.	Abbs, J. H., Hartman, D. E., & Vishwanat, B. (1987). Orofacial motor control impairment in Parkinson’s disease. Neurology37: 394–398.
A2.	Arnold, S. F., Klotz, D. M., Collins, B. M., Vonier, P. M., Guillette, L. J., Jr., & McLachlan, J. A. (1996). Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science272: 1489–1492.
A3.	Black, J. A., Friedman, B., Waxman, S. G., Elmer, L. W., & Angelides, K. J. (1989a). Immuno-ultrastructural localization of sodium channels at nodes of Ranvier and perinodal astrocytes in rat optic nerve. Proceedings of the Royal Society of London. Series B, Containing papers of a Biological character 238: 39–51.
A4.	Black, J. A., Waxman, S. G., Friedman, B., Elmer, L. W., & Angelides, K. J. (1989b). Sodium channels in astrocytes of rat optic nerve in situ: Immuno-electron microscopic studies. Glia 2: 353–369.
A5.	Blanc, P. D., Cisternas, M., Smith, S., & Yelin, E. (1996a). Occupational asthma in a community-based survey of adult asthma. Chest 109: 56S–57S.
A6.	Blanc, P. D., Cisternas, M., Smith, S., & Yelin, E. H. (1996b). Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists. Chest 109: 688–696.
*A7.	Blanc, P. D., Eisner, M. D., Israel, L., & Yelin, E. H. (1999). The association between occupation and asthma in general medical practice. Chest 115: 1259–1264.
A8.	Blanc, P. D., Katz, P. P., Henke, J., Smith, S., & Yelin, E. H. (1997a). Pulmonary and allergy subspecialty care in adults with asthma. Treatment, use of services, and health outcomes. Western Journal of Medicine 167: 398–407.
A9.	Blanc, P. D., Kuschner, W. G., Katz, P. P., Smith, S., & Yelin, E. H. (1997b). Use of herbal products, coffee or black tea, and over-the-counter medications as self-treatments among adults with asthma. Journal of Allergy and Clinical Immunology 100: 789–791.
A10.	Chao, J., Jin, L., Lin, K. F., & Chao, L. (1997). Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertension Research 20: 269–277.
A11.	Clayton, G. M., Dudley, W. N., Patterson, W. D., Lawhorn, L. A., Poon, L. W., Johnson, M. A., et al. (1994). The influence of rural/urban residence on health in the oldest-old. International Journal of Aging & Human Development38: 65–89.
A12.	Constantoulakis, P., Campbell, M., Felber, B. K., Nasioulas, G., Afonina, E., & Pavlakis, G. N. (1993). Inhibition of Rev-mediated HIV-1 expression by an RNA binding protein encoded by the interferon-inducible 9–27 gene. Science259: 1314–1318.
A13.	Coon, J. S., Landay, A. L., & Weinstein, R. S. (1987). Advances in flow cytometry for diagnostic pathology. Laboratory Investigation 57: 453–479.
A14.	Courtenay, B. C., Poon, L. W., Martin, P., Clayton, G. M., & Johnson, M. A. (1992). Religiosity and adaptation in the oldest-old. International Journal of Aging & Human Development 34: 47–56.
A15.	Cunha, F. Q., Weiser, W. Y., David, J. R., Moss, D. W., Moncada, S., & Liew, F. Y. (1993). Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. Journal of Immunology 150: 1908–1912.
A16.	Duan, L., Bagasra, O., Laughlin, M. A., Oakes, J. W., & Pomerantz, R. J. (1994). Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proceedings of the National Academy of Sciences of the United States of America91: 5075–5079.
A17.	Eisner, M. D., Katz, P. P., Yelin, E. H., Henke, J., Smith, S., & Blanc, P. D. (1998a). Assessment of asthma severity in adults with asthma treated by family practitioners, allergists, and pulmonologists. Medical Care 36: 1567–1577.
*A18.	Eisner, M. D., Yelin, E. H., Henke, J., Shiboski, S. C., & Blanc, P. D. (1998b). Environmental tobacco smoke and adult asthma. The impact of changing exposure status on health outcomes. American Journal of Respiratory and Clincal Care Medicine 158: 170–175.
A19.	Elmer, L. W., Black, J. A., Waxman, S. G., & Angelides, K. J. (1990). The voltage-dependent sodium channel in mammalian CNS and PNS: Antibody characterization and immunocytochemical localization. Brain Research 532: 222–231.
A20.	Friedman, A. J., & Hornstein, M. D. (1993). Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain. Fertility and Sterility60: 236–241.
A21.	Friedman, A. J., & Thomas, P. P. (1995). Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas? Obstetrics and Gynecology85: 631–635.
A22.	Garey, C. E., Schwarzman, A. L., Rise, M. L., & Seyfried, T. N. (1994). Ceruloplasmin gene defect associated with epilepsy in EL mice. Nature Genetics6: 426–431.
A23.	Hajra, A., & Collins, F. S. (1995). Structure of the leukemia-associated human CBFB gene. Genomics26: 571–579.
A24.	Hajra, A., Liu, P. P., & Collins, F. S. (1996). Transforming properties of the leukemic inv(16) fusion gene CBFB-MYH11. Current Topics in Microbiology and Immunology211: 289–298.
A25.	Hajra, A., Liu, P. P., Speck, N. A., & Collins, F. S. (1995a). Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein. Molecular and Cellular Biology15: 4980–4989.
A26.	Hajra, A., Liu, P. P., Wang, Q., Kelley, C. A., Stacy, T., Adelstein, R. S., et al. (1995b). The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells. Proceedings of the National Academy of Sciences of the United States of America92: 1926–1930.
A27.	Herman, T. S., Jochelson, M. S., Teicher, B. A., Scott, P. J., Hansen, J., Clark, J. R., et al. (1989). A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. International Journal of Radiation Oncology, Biology, Physics17: 1273–1279.
A28.	Huang, C. F., Flucher, B. E., Schmidt, M. M., Stroud, S. K., & Schmidt, J. (1994). Depolarization-transcription signals in skeletal muscle use calcium flux through L channels, but bypass the sarcoplasmic reticulum. Neuron13: 167–177.
A29.	Jiao, S., Gurevich, V., & Wolff, J. A. (1993). Long-term correction of rat model of Parkinson’s disease by gene therapy. Nature362: 450–453.
A30.	Johnson, M. A., Brown, M. A., Poon, L. W., Martin, P., & Clayton, G. M. (1992). Nutritional patterns of centenarians. International Journal of Aging & Human Development 34: 57–76.
*A31.	Katz, P. P., Eisner, M. D., Henke, J., Shiboski, S., Yelin, E. H., & Blanc, P. D. (1999). The Marks Asthma Quality of Life Questionnaire: Further validation and examination of responsiveness to change. Journal of Clinical Epidemiology 52: 667–675.
A32.	Katz, P. P., Yelin, E. H., Smith, S., & Blanc, P. D. (1997). Perceived control of asthma: Development and validation of a questionnaire. American Journal of Respiratory and Clincal Care Medicine 155: 577–582.
A33.	Kong, H., Raynor, K., Yasuda, K., Moe, S. T., Portoghese, P. S., Bell, G. I., Reisine, T. (1993). A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. Journal of Biological Chemistry 268: 23055–23058.
A34.	Kumar, V., Urban, J. L., & Hood, L. (1989). In individual T cells one productive alpha rearrangement does not appear to block rearrangement at the second allele. Journal of Experimental Medicine170: 2183–2188.
A35.	Kumar, V., Urban, J. L., Horvath, S. J., & Hood, L. (1990). Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America87: 1337–1341.
A36.	Landay, A., Jennings, C., Forman, M., & Raynor, R. (1993). Whole blood method for simultaneous detection of surface and cytoplasmic antigens by flow cytometry. Cytometry14: 433–440.
A37.	Lee, C. Q., Yun, Y. D., Hoeffler, J. P., & Habener, J. F. (1990). Cyclic-AMP-responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains. EMBO Journal9: 4455–4465.
A38.	Lee, T. S., Chao, T., Hu, K. Q., & King, G. L. (1989a). Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cells. Biochemical and Biophysical Research Communications162: 381–386.
A39.	Lee, T. S., Hu, K. Q., Chao, T., & King, G. L. (1989b). Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes38: 1643–1646.
A40.	Lee, T. S., MacGregor, L. C., Fluharty, S. J., & King, G. L. (1989c). Differential regulation of protein kinase C and (NA,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. Journal of Clinical Investigation83: 90–94.
A41.	Lee, T. S., Saltsman, K. A., Ohashi, H., & King, G. L. (1989d). Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications. Proceedings of the National Academy of Sciences of the United States of America86: 5141–5145.
A42.	Levy-Mintz, P., Duan, L., Zhang, H., Hu, B., Dornadula, G., Zhu, M., et al. (1996). Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. Journal of Virology 70: 8821–8832.
A43.	Liburdy, R. P. (1992a). Biological interactions of cellular systems with time-varying magnetic fields. Annals of the New York Academy of Sciences649: 74–95.
A44.	Liburdy, R. P. (1992b). Calcium signaling in lymphocytes and ELF fields. Evidence for an electric field metric and a site of interaction involving the calcium ion channel. FEBS Letters301: 53–59.
A45.	Lin, K. F., Chao, J., & Chao, L. (1995). Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension26: 847–853.
A46.	Lin, K. F., Chao, J., & Chao, L. (1998). Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Human Gene Therapy9: 1429–1438.
A47.	Liu, P. P., Hajra, A., Wijmenga, C., & Collins, F. S. (1995). Molecular pathogenesis of the chromosome 16 inversion in the M4EO subtype of acute myeloid leukemia. Blood 85: 2289–2302.
A48.	Liu, P. P., Wijmenga, C., Hajra, A., Blake, T. B., Kelley, C. A., Adelstein, R. S., et al. (1996). Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in INV(16) leukemia cells. Genes Chromosomes Cancer 16: 77–87.
A49.	London, J. A. (1990). Optical-recording of activity in the hamster gustatory cortex elicited by electrical-stimulation of the tongue. Chemical Senses15: 137–143.
A50.	London, J. A., & Wehby, R. G. (1994). Classification of inhibitory responses of the hamster gustatory cortex. Brain Research666: 270–274.
A51.	MacNeill, C., French, R., Evans, T., Wessels, A., & Burch, J. B. (2000). Modular regulation of CGATA-5 gene expression in the developing heart and gut. Developmental Biology 217: 62–76.
A52.	Martin, P., Poon, L. W., Clayton, G. M., Lee, H. S., Fulks, J. S., & Johnson, M. A. (1992). Personality, life events and coping in the oldest-old. International Journal of Aging & Human Development 34: 19–30.
A53.	Matsuguchi, T., Inhorn, R. C., Carlesso, N., Xu, G., Druker, B., & Griffin, J. D. (1995). Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO Journal14: 257–265.
A54.	Minturn, J. E., Sontheimer, H., Black, J. A., Angelides, K. J., Ransom, B. R., Ritchie, J. M., et al. (1991). Membrane-associated sodium channels and cytoplasmic precursors in glial cells. Immunocytochemical, electrophysiological, and pharmacological studies. Annals of the New York Academy of Sciences 633: 255–271.
A55.	Ninnemann, J. L. (1978). Melanoma-associated immunosuppression through B cell activation of suppressor T cells. Journal of Immunology120: 1573–1579.
A56.	Ninnemann, J. L. (1980). Immunosuppression following thermal injury through B cell activation of suppressor T cells. Journal of Trauma20: 206–213.
A57.	Ninnemann, J. L., Condie, J. T., Davis, S. E., & Crockett, R. A. (1982). Isolation immunosuppressive serum components following thermal injury. Journal of Trauma22: 837–844.
A58.	Ninnemann, J. L., & Ozkan, A. N. (1985). Definition of a burn injury-induced immunosuppressive serum component. Journal of Trauma25: 113–117.
A59.	Ninnemann, J. L., & Ozkan, A. N. (1987). The immunosuppressive activity of C1q degradation peptides. Journal of Trauma27: 119–122.
A60.	Ninnemann, J. L., Ozkan, A. N., & Sullivan, J. J. (1985). Hemolysis and suppression of neutrophil chemotaxis by a low molecular weight component of human burn patient sera. Immunology Letters10: 63–69.
A61.	Ninnemann, J. L., & Stockland, A. E. (1984). Participation of prostaglandin E in immunosuppression following thermal injury. Journal of Trauma24: 201–207.
A62.	Ninnemann, J. L., Stockland, A. E., & Condie, J. T. (1983). Induction of prostaglandin synthesis-dependent suppressor cells with endotoxin: Occurrence in patients with thermal injuries. Journal of Clinical Immunology3: 142–150.
A63.	Ozkan, A. N., & Ninnemann, J. L. (1987). Reversal of SAP-induced immunosuppression and SAP detection by a monoclonal antibody. Journal of Trauma 27: 123–126.
A64.	Paparo, A. A., & Murphy, J. A. (1975a). The effect of STH and 6-oh-dopa on the SEM of the branchial nerve and visceral ganglion of the bivalve elliptio complanata as it relates to ciliary activity. Comparative Biochemistry and Physiology. Part C, Toxicology & Pharmacology51: 169–170.
A65.	Paparo, A. A., & Murphy, J. A. (1975b). The effect of sth on the sem and frequency response of the branchial nerve in mytilus edulis as it relates to ciliary activity. Comparative Biochemistry and Physiology. Part C, Toxicology & Pharmacology51: 165–167.
A66.	Paul, S., Belinsky, M. G., Shen, H., & Kruh, G. D. (1996a). Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein. Biochemistry35: 13647–13655.
A67.	Paul, S., Breuninger, L. M., & Kruh, G. D. (1996b). ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing hl60/ADR cells. Biochemistry35: 14003–14011.
A68.	Paul, S., Breuninger, L. M., Tew, K. D., Shen, H., & Kruh, G. D. (1996c). ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes mrp as a broad specificity transporter. Proceedings of the National Academy of Sciences of the United States of America93: 6929–6934.
A69.	Poon, L. W., Martin, P., Clayton, G. M., Messner, S., Noble, C. A., & Johnson, M. A. (1992). The influences of cognitive resources on adaptation and old age. International Journal of Aging & Human Development 34: 31–46.
A70.	Raynor, K., Kong, H., Hines, J., Kong, G., Benovic, J., Yasuda, K., Bell, G.I., Reisine, T. (1994). Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. Journal of Pharmacology and Experimental Therapeutics 270: 1381–1386.
A71.	Reisine, T., Kong, H., Raynor, K., Yano, H., Takeda, J., Yasuda, K., et al. (1993). Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase. Molecular Pharmacology44: 1016–1020.
A72.	Ritchie, J. M., Black, J. A., Waxman, S. G., & Angelides, K. J. (1990). Sodium channels in the cytoplasm of Schwann cells. Proceedings of the National Academy of Sciences of the United States of America 87: 9290–9294.
A73.	Rosner, M. H., De Santo, R. J., Arnheiter, H., & Staudt, L. M. (1991). Oct-3 is a maternal factor required for the first mouse embryonic division. Cell64: 1103–1110.
*A74.	Ross, D. E., Buchanan, R. W., Medoff, D., Lahti, A. C., & Thaker, G. K. (1998). Association between eye tracking disorder in schizophrenia and poor sensory integration. American Journal of Psychiatry 155: 1352–1357.
A75.	Roy, S. N., Kudryk, B., & Redman, C. M. (1995). Secretion of biologically active recombinant fibrinogen by yeast. Journal of Biological Chemistry270: 23761–23767.
A76.	Ruggiero, K. M., & Major, B. N. (1998). Group status and attributions to discrimination: Are low- or high-status group members more likely to blame their failure on discrimination? Personality and Social Psychology Bulletin24: 821–827.
A77.	Ruggiero, K. M., & Marx, D. M. (1999). Less pain and more to gain: Why high-status group members blame their failure on discrimination. Journal of Personality and Social Psychology77: 774–784.
A78.	Ruggiero, K. M., Mitchell, J. P., Krieger, N., Marx, D. M., & Lorenzo, M. L. (2000a). Now you see it, now you don’t: Explicit versus implicit measures of the personal/group discrimination discrepancy. Psychological Science11: 511–514.
A79.	Ruggiero, K. M., Steele, J., Hwang, A., & Marx, D. M. (2000b). “Why did I get a ‘D’?”–the effects of social comparisons on women’s attributions to discrimination. Personality and Social Psychology Bulletin26: 1271–1283.
A80.	Schwarz, R. E., & Hiserodt, J. C. (1988). The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human LEU-19+/CD3- natural killer lymphocytes. Journal of Immunology 141: 3318–3323.
A81.	Shen, H., Paul, S., Breuninger, L. M., Ciaccio, P. J., Laing, N. M., Helt, M., et al. (1996). Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 35: 5719–5725.
A82.	Sherer, M. A. (1988). Intravenous cocaine: Psychiatric effects, biological mechanisms. Biological Psychiatry24: 865–885.
A83.	Sherer, M. A., Kumor, K. M., Cone, E. J., & Jaffe, J. H. (1988). Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings. Archives of General Psychiatry45: 673–677.
A84.	Siddiqui, F. A. (1983). Purification and immunological characterization of DNA polymerase-alpha from human acute lymphoblastic leukemia cells. Biochimica et Biophysica Acta745: 154–161.
A85.	Simmons, W. A., Leong, L. Y., Satumtira, N., Butcher, G. W., Howard, J. C., Richardson, J. A., et al. (1996). Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease. Journal of Immunology156: 1661–1667.
A86.	Simmons, W. A., Roopenian, D. C., Summerfield, S. G., Jones, R. C., Galocha, B., Christianson, G. J., et al. (1997a). A new MHC locus that influences Class I peptide presentation. Immunity7: 641–651.
A87.	Simmons, W. A., Summerfield, S. G., Roopenian, D. C., Slaughter, C. A., Zuberi, A. R., Gaskell, S. J., et al. (1997b). Novel hy peptide antigens presented by HLA-B27. Journal of Immunology159: 2750–2759.
A88.	Simmons, W. A., Taurog, J. D., Hammer, R. E., & Breban, M. (1993). Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse. Immunogenetics38: 351–358.
A89.	Srinivasula, S. M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., et al. (2001). A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112–116.
A90.	Stricker, R. B., Abrams, D. I., Corash, L., & Shuman, M. A. (1985). Target platelet antigen in homosexual men with immune thrombocytopenia. New England Journal of Medicine313: 1375–1380.
A91.	Sublett, J. E., Jeon, I. S., & Shapiro, D. N. (1995). The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Oncogene 11: 545–552.
A92.	Sun, W., & Chantler, P. D. (1992). Cloning of the CDNA encoding a neuronal myosin heavy chain from mammalian brain and its differential expression within the central nervous system. Journal of Molecular Biology224: 1185–1193.
A93.	Sun, W., Chen, X., & Chantler, P. D. (1994). Inhibition of neuritogenesis by antisense arrest of the expression of a specific isoform of brain myosin-II. Journal of Muscle Research and Cell Motility15: 184–185.
A94.	Sun, W. D., & Chantler, P. D. (1991). A unique cellular myosin II exhibiting differential expression in the cerebral cortex. Biochemical and Biophysical Research Communications175: 244–249.
A95.	Tewari, A., Buhles, W. C., Jr., & Starnes, H. F., Jr. (1990). Preliminary report: Effects of interleukin-1 on platelet counts. Lancet336: 712–714.
A96.	Urban, J. L., Horvath, S. J., & Hood, L. (1989). Autoimmune T cells: Immune recognition of normal and variant peptide epitopes and peptide-based therapy. Cell59: 257–271.
A97.	Urban, J. L., Kumar, V., Kono, D. H., Gomez, C., Horvath, S. J., Clayton, J., et al. (1988). Restricted use of T cell receptor v genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell54: 577–592.
A98.	Weiser, W. Y., Pozzi, L. M., & David, J. R. (1991). Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. Journal of Immunology147: 2006–2011.
A99.	Weiser, W. Y., Pozzi, L. M., Titus, R. G., & David, J. R. (1992). Recombinant human migration inhibitory factor has adjuvant activity. Proceedings of the National Academy of Sciences of the United States of America89: 8049–8052.
A100.	Wijmenga, C., Gregory, P. E., Hajra, A., Schrock, E., Ried, T., Eils, R., et al. (1996). Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells. Proceedings of the National Academy of Sciences of the United States of America 93: 1630–1635.
*A101.	Yelin, E., Henke, J., Katz, P. P., Eisner, M. D., & Blanc, P. D. (1999). Work dynamics of adults with asthma. American Journal of Industrial Medicine 35: 472–480.
A102.	Zhou, M., Sayad, A., Simmons, W. A., Jones, R. C., Maika, S. D., Satumtira, N., et al. (1998). The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. Journal of Experimental Medicine 188: 877–886.

1. *  The person named as responsible for the scientific misconduct (the respondent) was not a co-author on this paper